Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US5602116 | SANOFI | Method for treating and preventing secondary hyperparathyroidism |
Feb, 2014
(10 years ago) | |
US6903083 | SANOFI | Stabilized hydroxyvitamin D |
Jul, 2021
(2 years ago) | |
US7148211 | SANOFI | Formulation for lipophilic agents |
Sep, 2023
(7 months ago) |
Market Authorisation Date: 06 April, 2000
Treatment: Reduction of elevated ipth levels in the mgt of secondary hyperparathyroidism in patients undergong chronic renal dialysis
Dosage: INJECTABLE;INJECTION; CAPSULE;ORAL